Increased Marijuana Consumption Did Not Always Track Measured Tolerance in a 1975 Study

A 1975 residential study found that consumption tended to rise in both moderate and heavy marijuana users, while the reported tolerance measures changed mainly in heavy users. Increasing use was therefore not a sufficient indicator of tolerance on those endpoints.

The study followed self-administered smoking

Participants had access to specified marijuana cigarettes during a twenty-one-day smoking period within a longer study. Heavy users consumed more cigarettes daily than moderate users. Cigarette number describes consumption but does not directly quantify absorbed THC or establish equivalent smoking behavior.

The groups differed in adaptation

Heavy users reported declining intoxication ratings and shorter pulse-rate effects over time. Moderate users did not show corresponding changes in those measures. Because both groups tended to increase consumption, that increase alone did not identify who showed measurable tolerance.

The conclusion should remain endpoint-specific

The authors linked heavy repeated dosing to their measured adaptation pattern. The experiment did not establish that moderate users cannot become tolerant on other tasks or that every heavy user is unimpaired. Existing use history and self-selected dosing also limit a purely causal interpretation of the group difference.

The useful distinction is between more consumption, reduced subjective effect and a shorter cardiovascular response. They may be related without being interchangeable. This historical study cannot diagnose a substance-use disorder from cigarette counts or establish an individual's functional capacity after cannabis.

Related: interpreting cannabis tolerance claims.

Research cited

Babor TF; Mendelson JH; Greenberg I; Kuehnle JC. Marijuana consumption and tolerance to physiological and subjective effects. Archives of general psychiatry (1975). doi:10.1001/archpsyc.1975.01760300086007. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A 2026 Cannabis Review Explains Why Potency, Placebo Response and Sedation Need Separate Measures

A 2026 narrative review argues that product potency is not the same as delivered THC dose and that placebo responses remain important among experienced users. Its laboratory framework also distinguishes reduced drug reinforcement from nonspecific sedation. Users can change how they inhale The review notes that participants alter inhalation patterns…

Spread the love

Read Article: A 2026 Cannabis Review Explains Why Potency, Placebo Response and Sedation Need Separate Measures

THC Antinociception Persisted Without the Same Dynorphin Signal in Tolerant Rats

A 1999 rat study found that tolerance weakened THC-related modulation of spinal dynorphin, while antinociception could still occur without the same elevated dynorphin measure. The role of a downstream signal changed with dose and adaptive state. The experiment examined spinal responses The work followed earlier findings linking acute intrathecal THC…

Spread the love

Read Article: THC Antinociception Persisted Without the Same Dynorphin Signal in Tolerant Rats

A Passiflora-Derived Fraction Reduced THC Withdrawal Signs in a Mouse Model

A 2002 mouse experiment reported fewer antagonist-precipitated withdrawal signs with a Passiflora-derived benzoflavone fraction. The finding concerns a defined experimental preparation and animal model, not a demonstrated treatment for cannabis-use disorder in people. Concurrent and acute interventions were tested Mice received repeated oral THC with or without the fraction. A…

Spread the love

Read Article: A Passiflora-Derived Fraction Reduced THC Withdrawal Signs in a Mouse Model

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us